🏛️ Verified NIH Record • Updated 2025-09-04
Pounce™ Thrombectomy System Retrospective Registry (NCT05868161)
🟢 Recruiting Interventional Protocol 📊 Observational Clinical Research Sponsor: SurModics, Inc.
🩺 Plain-English Summary (8th-Grade Level)
The PROWL registry is an open-label retrospective, multi-center, US study of the Surmodics™ Pounce™ Thrombectomy System for the non-surgical removal of emboli and thrombi in the peripheral arterial vasculature.
Who can join: Review the eligibility criteria below.
Location: OSF St. Francis Medical Center — Peoria, Illinois
Age range: 18 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (9 Sites)
- OSF St. Francis Medical Center — Peoria, Illinois
- Community Hospital — Munster, Indiana
- Baton Rouge General Medical Center — Baton Rouge, Louisiana
- Allina Health — Minneapolis, Minnesota
- Cleveland Clinic — Cleveland, Ohio
- Prisma Health Upstate — Greenville, South Carolina
- North Central Heart — Sioux Falls, South Dakota
- Vanderbilt University Medical Center — Nashville, Tennessee
- Ascension Seton — Austin, Texas
📞 Contact the Study Coordinator
Phone: (866) 787-6639
Email: PROWLRegistry@surmodics.com
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Peripheral Arterial Disease
- SELUTION4SFA Trial — Little Rock, Arkansas
- SCOPE-CLI: Shifting Care and Outcomes for Patients With Endangered Limbs — New Haven, Connecticut
- A Clinical Evaluation of the MicroSTent® PeripherAl Vascular SteNt in Subjects With Arterial Disease Below the Knee (STAND) — Birmingham, Alabama
- Shortwave Diathermy In-home Treatment for Indianapolis VA-only Patients Diagnosed With Peripheral Artery Disease and Peripheral Neuropathy — Indianapolis, Indiana
- FGF-1 for Intramuscular Injection for the Treatment of Peripheral Arterial Disease — Chicago, Illinois
- MitoQ Treatment of Claudication: Myofiber and Micro-vessel Pathology — Omaha, Nebraska
Explore by condition: All Peripheral Arterial Disease clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.